The Global Health Observatory

Explore a world of health data

Table
Indicator name:
Availability of investigational pharmaceutical trials for dementia
Indicator Id:
5268
Rationale:
Research participation is crucial to the conduct of studies in humans and to monitoring and contributing to the research process. It can also be regarded as additional support and has been shown to be potentially beneficial due to an improved understanding of dementia, its impact on both people with dementia and their carers, and more regular health checks involved in trial protocols.
Definition:
Existence of investigational pharmaceutical trials for dementia. This includes multi-centre trials or trials headquartered /coordinated elsewhere with a site in the country
Method of estimation:
Existence of relevant opportunities to participate in research through access to longitudinal cohort studies, clinical trials, selection of successful grant applications or formal contributions to the research process. Provided by the national authority's response.
Data Type Representation:
Categorical
IMRID:
5268
Original Submeasure:
Are investigational pharmaceutical trials for dementia (Phase II to IV) available in your country?
Indicator Metadata Registry List
Availability of investigational pharmaceutical trials for dementia
If you have any feedback, you are welcome to write it here.
If you need to access the old Global Health Observatory data, you can do it here. But before you leave, please provide us your feedback about our new data portal.